Virus envelope vector for gene transfer

Details Virus envelope vector for gene transfer Virus envelope vector for gene transfer

2007-10-09

2007-10-09

Whiteman, Brian (Department: 1635)

Chemistry: molecular biology and microbiology

Process of mutation, cell fusion, or genetic modification

Introduction of a polynucleotide molecule into or...

Reexamination Certificate

active

10824757

ABSTRACT:
A gene transfer vector is prepared by introducing an exogenous gene into an inactivated virus envelope, through a freezing and thawing treatment or mixing with a detergent. There are also provided a pharmaceutical composition for gene therapy containing this gene transfer vector, a kit containing this gene transfer vector, and a gene transfer method employing this gene transfer vector.

REFERENCES:
patent: 4266024 (1981-05-01), Swetly et al.
patent: 5244635 (1993-09-01), Rabson et al.
patent: 5683866 (1997-11-01), Sarkar et al.
patent: 5846707 (1998-12-01), Roizman
patent: 5849561 (1998-12-01), Falck-Pedersen
patent: 5879685 (1999-03-01), Gluck et al.
patent: 6020202 (2000-02-01), Jessee
patent: 6051428 (2000-04-01), Fong et al.
patent: 6183752 (2001-02-01), Epstein et al.
patent: 6372957 (2002-04-01), Olson
patent: 6432925 (2002-08-01), Hoon et al.
patent: 6451592 (2002-09-01), Dubensky, Jr. et al.
patent: 6472375 (2002-10-01), Hoon et al.
patent: 6509162 (2003-01-01), Altieri
patent: 6670176 (2003-12-01), Samulski et al.
patent: 6913923 (2005-07-01), Kaneda
patent: 0 555 333 (1995-12-01), None
Kwong et al. Journal of Virology 51:595-603, 1984.
Ramani et al.PNAS95:11886-11890, 1998.
Lee et al.,Virology128:65-76, 1983.
Microbiology & Immunology: BS3035: Paramyxoviruses [online], Jan. 21, 2003 [retrieved on Apr. 9, 2003]. Retrieved from the Internet:<URL:http://www-micro.msb.le.ac.uk/3035paramyxoviruses.html>.
Swaney et al.,Gene Therapy4:1379-1386, 1997.
Ramani, K. et al., “Novel gene delivery to liver cells using engineered virosomes,”FEBS Letters404, pp. 164-168, 1997.
Vlasov, V. et al., “The efficient method for DNA incorporation into reconstituted Sendai virus envelopes,”Chemical Abstracts,109(25):411, abstract 226002h(1988), abstract only.
Fields, B.N. et al.,Virology,Lipincott Williams & Wilkins, pp. 1177-1204, 1996.
Harmsen, M.C. et al., “Reconstitution and Fusogenic Properties of Sendai Virus Envelopes”,Eur J. Biochem,vol. 149, No. 3, pp. 591-600, 1985.
Mulligan,Science260:926-932, 1993.
Ledley,Human Gene Therapy,6:1129-1144, 1995.
Cole, et al.,J Immunology158:4301-4309, 1997.
Uchida, et al.,J. Cell Biol.80:10-20, 1979.
Dzau, et al.,Proc. Natl. Acad. Sci. USA93:11421-11425, 1996.
Kaneda, et al.,Molecular Medicine Today5:298-303, 1999.
Okada, et al.,Biken's Journal4:209-213, 1961.
Bagai, et al.,Journal of Virology67(6):3312-3318, 1993.
Cotten et al., “Psoralen Treatment of Adenovirus Particles Eliminates Virus Replication and Transcription While Maintaining the Endosomolytic Activity of the Virus Capsid”,Virology,205254-261 (1984).
Hangai et al., “In Vivo Delivery of Phosphorothioate Oligonucleotides Into Murine Retina”,Arch Ophthalmol.,116:342-348 (1998).
Kim et al. “Effect of Lipid Compositions on Gene Transfer into 293 Cells Using Sendai F/HN-Virosomes”,Journal of Biochemistry and Molecular Biology,35(5):459-464 (2002).
Nakanishi et al., “Glycoproteins of Sendai Virus (HVJ) Have A Critical Ratio for Fusion Between Virus Envelopes and Cell Membranes”,Exp Cell Research,pp. 143-151(1982).
Nakanishi et al., “Preparation of Unilamellar Fusogenic Liposomes Using the Sendai Virus”,Folia Pharmacol. Jpn.,112:299-305 (English Abstract) (1998).
Otsuji et al., “In Vivo Gene Transfer into Choroidal Neovascularization by the HVJ Liposome Method”,Graefe's Arch Clin Exp Ophthalmol,238:191-199 (2000).
Paternostre et al., “Solubilization and Reconstitution of Vesicular Stomatitis Virus Envelope Using Octylglucoside”Biophysical Journal,72:1683-1694 (1997).
Race et al., “A Multistep Procedure for the Chemical Inactivation of Human Immunodeficiency Virus for Use as an Experimental Vaccine”,Vaccine,13(15):1567-1575 (1995).
Saeki et al., “Development and Characterization of Cationic Liposomes Conjugated with HVJ (Sendai Virus): Reciprocal Effect of Cationic Lipid for In Vitro and In Vivo Gene Transfer”,Human Gene Therapy,8:2133-2141 (1997).
Vainstein et al., “A New Method for Reconstitution of Highly Fusogenic Sendai Virus Envelopes”,Biochimica et Biophysica ACTA,773:184-188 (1984).

Affiliated with

Also associated with

Rating

Virus envelope vector for gene transfer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Virus envelope vector for gene transfer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Virus envelope vector for gene transfer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3889329